Mengchao Cui

3.3k total citations
132 papers, 2.8k citations indexed

About

Mengchao Cui is a scholar working on Physiology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Mengchao Cui has authored 132 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Physiology, 31 papers in Radiology, Nuclear Medicine and Imaging and 30 papers in Molecular Biology. Recurrent topics in Mengchao Cui's work include Alzheimer's disease research and treatments (78 papers), Radiopharmaceutical Chemistry and Applications (22 papers) and Computational Drug Discovery Methods (22 papers). Mengchao Cui is often cited by papers focused on Alzheimer's disease research and treatments (78 papers), Radiopharmaceutical Chemistry and Applications (22 papers) and Computational Drug Discovery Methods (22 papers). Mengchao Cui collaborates with scholars based in China, Japan and United States. Mengchao Cui's co-authors include Boli Liu, Jiapei Dai, Hideo Saji, Masahiro Ono, Hualong Fu, Hiroyuki Kimura, Kaixiang Zhou, Yanping Yang, Hiroyuki Watanabe and Yuying Li and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and NeuroImage.

In The Last Decade

Mengchao Cui

125 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengchao Cui China 29 1.4k 784 566 519 506 132 2.8k
Chongzhao Ran United States 32 1.4k 1.0× 871 1.1× 619 1.1× 771 1.5× 577 1.1× 123 3.8k
Boli Liu China 28 770 0.6× 547 0.7× 269 0.5× 392 0.8× 290 0.6× 104 2.4k
Hiroyuki Kimura Japan 25 840 0.6× 524 0.7× 260 0.5× 293 0.6× 345 0.7× 80 2.0k
Claudio O. Fernández Argentina 39 2.4k 1.8× 1.9k 2.5× 421 0.7× 494 1.0× 176 0.3× 86 5.3k
Carlos W. Bertoncini Argentina 30 2.0k 1.4× 1.9k 2.4× 403 0.7× 525 1.0× 108 0.2× 34 4.4k
Guo-Feng Huang United States 10 1.7k 1.2× 606 0.8× 96 0.2× 199 0.4× 288 0.6× 10 2.5k
Mei‐Ping Kung United States 25 1.3k 0.9× 799 1.0× 86 0.2× 179 0.3× 315 0.6× 47 2.4k
Shozo Furumoto Japan 35 2.0k 1.5× 857 1.1× 103 0.2× 180 0.3× 312 0.6× 141 4.0k
Zhefeng Guo United States 17 881 0.6× 867 1.1× 233 0.4× 297 0.6× 143 0.3× 36 1.7k
Leila M. Luheshi United Kingdom 19 2.0k 1.4× 2.0k 2.6× 113 0.2× 233 0.4× 299 0.6× 26 3.1k

Countries citing papers authored by Mengchao Cui

Since Specialization
Citations

This map shows the geographic impact of Mengchao Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengchao Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengchao Cui more than expected).

Fields of papers citing papers by Mengchao Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengchao Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengchao Cui. The network helps show where Mengchao Cui may publish in the future.

Co-authorship network of co-authors of Mengchao Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Mengchao Cui. A scholar is included among the top collaborators of Mengchao Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengchao Cui. Mengchao Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yimin, Ming Wang, Xinlin Wang, et al.. (2025). Biphenyl-Trimeric PSMA Theranostic Platform Enables PET Imaging and Optical Detection of Prostate Cancer. Journal of Medicinal Chemistry. 68(12). 13075–13088.
2.
Li, Yuying, Liling Dong, Qi Ge, et al.. (2025). The diagnostic performance of [18F]Florbetazine in Alzheimer’s disease: a head-to-head comparison to [11C]PiB and [18F]Florbetapir. European Journal of Nuclear Medicine and Molecular Imaging. 52(10). 3557–3566.
3.
Chen, Yimin, Ming Ni, Xiaojun Zhang, et al.. (2025). Preclinical Evaluation and First-in-Human PET Study of Al18F-Labeled Biphenyl-Based Dimeric PSMA Tracers. Journal of Medicinal Chemistry. 68(6). 6832–6843. 2 indexed citations
4.
Wang, Xinlin, Ming Wang, Yimin Chen, et al.. (2025). Preclinical evaluation and first-in-human study of 68Ga- and Al18F-Labeled PSMA/FAP bispecific tracers for prostate cancer imaging. European Journal of Nuclear Medicine and Molecular Imaging. 53(4). 2489–2501.
5.
Zhang, Xiaojun, Jie Ma, Kaixiang Zhou, et al.. (2024). Structure-based discovery of a 4,5-Dihydropyrazole-cored PET ligand for imaging of receptor-interacting serine/threonine-protein kinase 1 (RIPK1) in the brain. European Journal of Medicinal Chemistry. 279. 116803–116803. 2 indexed citations
6.
Ni, Ming, Xingxing Zhu, Kaixuan Wang, et al.. (2024). Novel β-amyloid PET Imaging Study of [18F]92 in Patients with Cognitive Decline. ACS Omega. 9(32). 34675–34683. 1 indexed citations
7.
Cao, Lu, Yuying Li, Xiaojun Ren, et al.. (2024). A probe for NIR-II imaging and multimodal analysis of early Alzheimer’s disease by targeting CTGF. Nature Communications. 15(1). 5000–5000. 21 indexed citations
8.
Ren, Chao, Chenhui Mao, Liling Dong, et al.. (2024). Evaluation of a novel PET tracer [18F]-Florbetazine for Alzheimer's disease diagnosis and β-amyloid deposition quantification. NeuroImage. 298. 120779–120779. 2 indexed citations
9.
Wang, Xinlin, Xiaojun Zhang, Lili Guan, et al.. (2024). Design, preclinical evaluation, and first-in-human PET study of [68Ga]Ga-PSFA-01: a PSMA/FAP heterobivalent tracer. European Journal of Nuclear Medicine and Molecular Imaging. 52(3). 1166–1176. 5 indexed citations
10.
Wang, Ying, Li Cai, Kaixiang Zhou, Mengchao Cui, & Shaobo Yao. (2022). Biodistribution and Dosimetry Evaluation for a Novel Tau Tracer [18F]-S16 in Healthy Volunteers and Its Application in Assessment of Tau Pathology in Alzheimer’s Disease. Frontiers in Bioengineering and Biotechnology. 9. 812818–812818. 6 indexed citations
11.
Zhang, Ying, Tao Wang, Xiaojun Zhang, et al.. (2021). Discovery and development of brain-penetrant 18F-labeled radioligands for neuroimaging of the sigma-2 receptors. Acta Pharmaceutica Sinica B. 12(3). 1406–1415. 10 indexed citations
12.
Hyeon, Seung Jae, Essam Eldin A. Osman, Sungsu Lim, et al.. (2021). “Turn-On” Quinoline-Based Fluorescent Probe for Selective Imaging of Tau Aggregates in Alzheimer’s Disease: Rational Design, Synthesis, and Molecular Docking. ACS Sensors. 6(6). 2281–2289. 43 indexed citations
13.
Li, Yuying, Kan Wang, Kaixiang Zhou, et al.. (2018). Novel D–A–D based near-infrared probes for the detection of β-amyloid and Tau fibrils in Alzheimer's disease. Chemical Communications. 54(63). 8717–8720. 50 indexed citations
14.
Li, Zijing, Mengchao Cui, Jinming Zhang, et al.. (2014). Novel 18F-labeled dibenzylideneacetone derivatives as potential positron emission tomography probes for in vivo imaging of β-amyloid plaques. European Journal of Medicinal Chemistry. 84. 628–638. 10 indexed citations
15.
Cui, Mengchao. (2013). Past and Recent Progress of Molecular Imaging Probes for β-Amyloid Plaques in the Brain. Current Medicinal Chemistry. 21(1). 82–112. 65 indexed citations
16.
Wang, Xuedan, Mengchao Cui, Pingrong Yu, et al.. (2012). Synthesis and biological evaluation of novel technetium-99m labeled phenylbenzoxazole derivatives as potential imaging probes for β-amyloid plaques in brain. Bioorganic & Medicinal Chemistry Letters. 22(13). 4327–4331. 21 indexed citations
17.
Cui, Mengchao, Masahiro Ono, Hiroyuki Kimura, Boli Liu, & Hideo Saji. (2011). Novel quinoxaline derivatives for in vivo imaging of β-amyloid plaques in the brain. Bioorganic & Medicinal Chemistry Letters. 21(14). 4193–4196. 26 indexed citations
18.
Cui, Mengchao, et al.. (2011). Novel (E)-5-styryl-2,2′-bithiophene derivatives as ligands for β-amyloid plaques. European Journal of Medicinal Chemistry. 46(7). 2908–2916. 16 indexed citations
19.
Ono, Masahiro, Hiroyuki Kimura, Kenji Matsumura, et al.. (2010). Development of dual functional SPECT/fluorescent probes for imaging cerebral β-amyloid plaques. Bioorganic & Medicinal Chemistry Letters. 20(13). 3885–3888. 61 indexed citations
20.
Qiao, Jinping, et al.. (2009). Novel anilinophthalimide derivatives as potential probes for β-amyloid plaque in the brain. Bioorganic & Medicinal Chemistry. 18(3). 1337–1343. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chongzhao Ran Breakdown of academic impact, for papers by Boli Liu Breakdown of academic impact, for papers by Hiroyuki Kimura Breakdown of academic impact, for papers by Claudio O. Fernández Breakdown of academic impact, for papers by Carlos W. Bertoncini Breakdown of academic impact, for papers by Guo-Feng Huang Breakdown of academic impact, for papers by Mei‐Ping Kung Breakdown of academic impact, for papers by Shozo Furumoto Breakdown of academic impact, for papers by Zhefeng Guo Breakdown of academic impact, for papers by Leila M. Luheshi
Rankless by CCL
2026